TVTX
Travere Therapeutics Inc
52.00$
-2.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +278.2% | +2.5% | -0.9% | +36.3% | -14.7% | +0.4% | +27.9% | -13.4% | +17.3% | -24.7% | +1.9% | |
| – | +708.7% | +10.1% | -2.0% | +52.1% | -13.4% | -4.3% | +42.0% | -16.5% | +26.8% | -32.4% | +5.0% | |
| – | +107.7% | +8.5% | +142.4% | +3.5% | -39.3% | +35.8% | +95.5% | -62.8% | -5.7% | +0.6% | +58.9% | |
| – | +727.1% | +11.4% | +17.5% | +56.9% | -15.5% | -9.3% | +52.9% | -18.6% | +25.9% | -34.6% | -12.9% | |
| – | +645.1% | +10.2% | -78.8% | +4.5% | +24.6% | +83.2% | -51.9% | +4.6% | +27.2% | +28.0% | +195.5% | |
| – | +216.8% | +11.4% | +89.3% | +5.0% | +8.2% | +25.1% | -3.9% | -38.2% | +108.0% | -34.1% | -5.2% | |
| – | – | – | – | -2.6% | -8.1% | +1,113.9% | -68.4% | -18.5% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -3.8% | -11.1% | -5.9% | +0.0% | – | |
| – | +71.4% | +12.7% | +1.5% | +1.0% | -15.8% | -2.6% | -3.7% | -34.7% | +7.7% | -0.5% | +9.6% | |
| – | +23.0% | +2.4% | +4.5% | +72.0% | -1.9% | +3.3% | +19.8% | +32.7% | -6.6% | -9.0% | -8.4% | |
| – | -20.2% | -3.0% | +2.9% | +22.1% | -8.8% | -2.9% | +33.9% | +14.6% | +25.1% | +12.8% | -20.3% | |
| – | – | – | – | – | -88.4% | -86.3% | +994.7% | +13.4% | +10.7% | +1,409.1% | -92.1% | |
| – | +7.2% | -1.5% | +151.8% | -63.3% | +282.7% | -54.4% | +24.8% | +14.2% | +141.0% | -43.5% | +5.4% | |
| – | – | – | – | +332.8% | +5.0% | +5.1% | +5.2% | +65.7% | +0.5% | -17.7% | +0.5% | |
| – | – | +2.6% | -4.8% | +8.6% | -30.5% | -4.5% | +43.0% | -85.8% | +368.6% | -70.6% | +94.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +50.0% | +1.9% | +1.3% | +4.3% | +4.7% | +12.3% | +25.9% | +6.6% | +16.5% | +6.2% | +13.1% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.